Page last updated: 2024-11-06

zopiclone and Anemia, Hemolytic

zopiclone has been researched along with Anemia, Hemolytic in 1 studies

zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fung, HT1
Lai, CH1
Wong, OF1
Lam, SK1
Lam, KK1

Other Studies

1 other study available for zopiclone and Anemia, Hemolytic

ArticleYear
Hemolytic anemia after zopiclone overdose.
    Clinical toxicology (Philadelphia, Pa.), 2009, Volume: 47, Issue:9

    Topics: Anemia, Hemolytic; Azabicyclo Compounds; Drug Overdose; Female; Follow-Up Studies; Humans; Hypnotics

2009